Gordon Kuntz

Tools for Transformation

Contemplating the Future of Oncology Pathways

10/18/2019

Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...

Gordon...

10/18/2019

Journal of Clinical Pathways

Tools for Transformation

Recognizing the Limitations Surrounding Clinical Pathways to Ensure Appropriate Use

02/18/2020

Gordon Kuntz ;

Gordon...

02/18/2020

Journal of Clinical Pathways

Tools for Transformation

Drivers and Projected Trends for Post-COVID-19 Cancer Care Operations

05/19/2020

Gordon Kuntz ;

Gordon...

05/19/2020

Journal of Clinical Pathways

Guest Blog

Adapting Pathways in a Pandemic

05/08/2020

Gordon Kuntz ;

Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.

Gordon Kuntz, Partner, Kuntz...

05/08/2020

Journal of Clinical Pathways

Special Article

Recommendations for Enhancing the Value of Clinical Pathways: Findings From the 2020 Care Pathways Working Group

11/16/2021

Winston Wong , PharmD;

Vasily Belozeroff , PhD;

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Experts identified concerns related to care pathways and their implementation that need to be addressed in order to promote high-quality pathways that offer utility in payer negotiation, reduce costs, and reduce unnecessary variation in care...

Experts identified concerns...

11/16/2021

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Tools for Transformation

What Do We Mean When We Talk About “Clinical Pathways”?

02/19/2019

Gordon Kuntz ;

Gordon...

02/19/2019

Journal of Clinical Pathways

Podcasts

Episode 6: Rapid Scientific Advancements in Value-Based Arrangements: Why Are Pathways Important?

06/29/2023

Aimee Ginsburg , PharmD, BCPS;

Gordon Kuntz ;

On episode 6 of Oncology Innovations, host Gordon Kuntz sits down with Aimee Ginsburg, PharmD, McKesson Value Pathways, to discuss the value of clinical pathways in a world of rapidly advancing scientific data, and how decision support tools...

On episode 6 of Oncology...

06/29/2023

Journal of Clinical Pathways

Tools for Transformation

First Things First: Deciding Why Your Practice Is Implementing Pathways

03/13/2019

Gordon Kuntz ;

Gordon...

03/13/2019

Journal of Clinical Pathways

Review

NGS Testing in Non–Small Cell Lung Cancer

09/19/2023

Winston Wong , PharmD;

Gordon Kuntz ;

Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...

Winston Wong, PharmD, and Gordon...

09/19/2023

Journal of Clinical Pathways